BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/15/2018 5:35:47 PM | Browse: 350 | Download: 499
Category |
Endocrinology & Metabolism |
Manuscript Type |
Observational Study |
Article Title |
Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Manfred Paul Stapff |
Funding Agency and Grant Number |
|
Corresponding Author |
Manfred Paul Stapff, MD, PhD, CMO, TriNetX Inc., 125 Cambridgepark Drive, Ste 500, Cambridge, MA 02140, United States. manfred.stapff@trinetx.com |
Key Words |
Sodium-glucose co-transporter-2 inhibitors; Cardiovascular events; Clinical trials; Electronic medical records; Dipeptidyl peptidase 4 inhibitors; Real world evidence; Diabetes |
Core Tip |
Core tip: Cardiovascular advantages of sodium-glucose co-transporter-2 (SGLT2) inhibitors were shown in complex clinical trials or in countries with large registries. However, it was unclear whether these findings could be applied to routine medical practice in the US. This real world analysis from 46909 patients with SGLT2 inhibitors revealed a 0.63 (95%CI: 0.60-0.66) risk ratio of SGLT2 inhibitors compared to 189120 patients with dipeptidyl peptidase 4 inhibitors. This analysis of electronic health records could replicate the results of randomized clinical trials, which supports the usefulness of such real world studies (e.g., for long-term outcome or safety observations). |
Citation |
Stapff MP. Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes. World J Diabetes 2018; 9(12): 252-257 |
|
Received |
|
2018-08-22 03:15 |
|
Peer-Review Started |
|
2018-08-22 09:05 |
|
To Make the First Decision |
|
2018-10-08 03:37 |
|
Return for Revision |
|
2018-10-10 02:23 |
|
Revised |
|
2018-10-10 15:57 |
|
Second Decision |
|
2018-11-14 11:18 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2018-11-15 17:35 |
|
Articles in Press |
|
2018-11-15 17:35 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2018-11-24 00:53 |
|
Typeset the Manuscript |
|
2018-12-03 03:07 |
ISSN |
1948-9358 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345